| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 57.23B | 47.06B | 43.24B | 37.84B | 33.32B |
| Gross Profit | 16.85B | 15.54B | 14.46B | 12.83B | 11.89B |
| EBITDA | 11.62B | 10.24B | 10.18B | 9.27B | 8.75B |
| Net Income | 6.46B | 5.81B | 5.97B | 5.42B | 4.93B |
Balance Sheet | |||||
| Total Assets | 110.39B | 116.31B | 112.79B | 100.31B | 97.65B |
| Cash, Cash Equivalents and Short-Term Investments | 8.86B | 10.39B | 7.92B | 6.68B | 6.21B |
| Total Debt | 42.64B | 43.98B | 44.48B | 45.56B | 46.62B |
| Total Liabilities | 60.23B | 70.70B | 69.68B | 59.69B | 60.03B |
| Stockholders Equity | 49.86B | 45.62B | 43.11B | 40.54B | 37.56B |
Cash Flow | |||||
| Free Cash Flow | 10.95B | 10.05B | 10.40B | 9.18B | 6.91B |
| Operating Cash Flow | 12.35B | 11.23B | 11.44B | 10.26B | 8.15B |
| Investing Cash Flow | -4.77B | 642.00M | -1.96B | -1.58B | 9.71B |
| Financing Cash Flow | -9.50B | -9.51B | -8.24B | -8.25B | -18.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥129.78B | 14.74 | ― | 2.09% | 5.78% | 10.26% | |
70 Outperform | ¥130.89B | 20.09 | ― | 0.70% | 5.15% | 47.13% | |
68 Neutral | ¥141.06B | 19.06 | ― | 1.88% | 16.70% | -0.37% | |
65 Neutral | ¥268.42B | 33.85 | 9.66% | 0.55% | 14.33% | 36.83% | |
63 Neutral | ¥739.84B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥62.02B | 17.62 | ― | 1.95% | 23.52% | -13.42% |